Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Oscient Pharmaceuticals Lays Off 180 Reps
PharmExec, 06/18/09
Oscient Pharmaceuticals, last week, announced that it will be ending all promotion activity for two of its treatments, and decreasing its sales force and marketing team by 180 bodies to compensate.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09
Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan
GlaxoSmithKline, 12/01/09
Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease
Shire, 11/30/09